Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery.
Henriksson M, Palmer S, Chen R, Damant J, Fitzpatrick NK, Abrams K, Hingorani AD, Stenestrand U, Janzon M, Feder G, Keogh B, Shipley MJ, Kaski JC, Timmis A, Sculpher M, Hemingway H. Henriksson M, et al. BMJ. 2010 Jan 19;340:b5606. doi: 10.1136/bmj.b5606. BMJ. 2010. PMID: 20085988 Free PMC article.
The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model.
Hemingway H, Henriksson M, Chen R, Damant J, Fitzpatrick N, Abrams K, Hingorani A, Janzon M, Shipley M, Feder G, Keogh B, Stenestrand U, McAllister K, Kaski JC, Timmis A, Palmer S, Sculpher M. Hemingway H, et al. Health Technol Assess. 2010 Feb;14(9):1-151, iii-iv. doi: 10.3310/hta14090. Health Technol Assess. 2010. PMID: 20184812 Free article. Review.
Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease.
Hemingway H, Philipson P, Chen R, Fitzpatrick NK, Damant J, Shipley M, Abrams KR, Moreno S, McAllister KS, Palmer S, Kaski JC, Timmis AD, Hingorani AD. Hemingway H, et al. Among authors: abrams kr. PLoS Med. 2010 Jun 1;7(6):e1000286. doi: 10.1371/journal.pmed.1000286. PLoS Med. 2010. PMID: 20532236 Free PMC article. Review.
Prognosis research strategy (PROGRESS) 4: stratified medicine research.
Hingorani AD, Windt DA, Riley RD, Abrams K, Moons KG, Steyerberg EW, Schroter S, Sauerbrei W, Altman DG, Hemingway H; PROGRESS Group. Hingorani AD, et al. BMJ. 2013 Feb 5;346:e5793. doi: 10.1136/bmj.e5793. BMJ. 2013. PMID: 23386361 Free PMC article.
Prognosis Research Strategy (PROGRESS) 2: prognostic factor research.
Riley RD, Hayden JA, Steyerberg EW, Moons KG, Abrams K, Kyzas PA, Malats N, Briggs A, Schroter S, Altman DG, Hemingway H; PROGRESS Group. Riley RD, et al. PLoS Med. 2013;10(2):e1001380. doi: 10.1371/journal.pmed.1001380. Epub 2013 Feb 5. PLoS Med. 2013. PMID: 23393429 Free PMC article. Review.
Prognosis Research Strategy (PROGRESS) 3: prognostic model research.
Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG; PROGRESS Group. Steyerberg EW, et al. PLoS Med. 2013;10(2):e1001381. doi: 10.1371/journal.pmed.1001381. Epub 2013 Feb 5. PLoS Med. 2013. PMID: 23393430 Free PMC article. Review.
270 results